• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria.

作者信息

Kristiansen J E, Vergmann B

出版信息

Acta Pathol Microbiol Immunol Scand B. 1986 Dec;94(6):393-8. doi: 10.1111/j.1699-0463.1986.tb03073.x.

DOI:10.1111/j.1699-0463.1986.tb03073.x
PMID:3105243
Abstract

The aim of the present investigation was to illustrate the antibacterial effect of various phenothiazine and thioxanthene derivatives on mycobacteria in vitro. It was demonstrated that clopenthixol is about twice as potent as chlorpromazine (CPZ) and levomepromazine-maleate is about half as potent as CPZ, measured by the inhibitory effect on the growth of the mycobacterial strains. Measured in the same way the stereoisomeric compounds of flupenthixol are shown to be more potent than the stereo-isomeric compounds of clopenthixol and chlorprothixen. The two last-named compounds are equal in potency. The stereo-isomeric analogs of the thioxanthene derivatives are equal in antibacterial potency against the slow-growing mycobacteria. The mycobacterial strains investigated show no difference in sensitivity between the cis (Z)--and and trans (E)--compounds of the thioxanthenes. It seems particularly promising that also the more resistant mycobacteria other than Mycobacterium tuberculosis, e.g. M. avium and M. intracellulare, are sensitive in the concentration range investigated. Considered as a whole, these results might be a stimulus to investigate the antimicrobial effect of the thioxanthenes in vivo.

摘要

相似文献

1
The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria.
Acta Pathol Microbiol Immunol Scand B. 1986 Dec;94(6):393-8. doi: 10.1111/j.1699-0463.1986.tb03073.x.
2
In vitro modulation of human neutrophil chemotaxis by cis(Z)- and trans(E)-clopenthixol, and chlorpromazine.
Acta Pathol Microbiol Immunol Scand C. 1985 Oct;93(5):199-203. doi: 10.1111/j.1699-0463.1985.tb02945.x.
3
Effect of some psychotropic drugs and a barbiturate on mycoplasmas.
Int J Antimicrob Agents. 2000 Apr;14(3):235-8. doi: 10.1016/s0924-8579(99)00160-0.
4
The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis(Z)- and trans(E)-clopenthixol.
Acta Pathol Microbiol Immunol Scand B. 1985 Jun;93(3):249-51. doi: 10.1111/j.1699-0463.1985.tb02884.x.
5
Stereo-isomeric dissociation of the antibacterial and the neuroleptic effect of clopenthixol.氯哌噻吨抗菌及抗精神病作用的立体异构解离
Acta Pathol Microbiol Scand B. 1981 Dec;89(6):437-8.
6
The antibacterial activity of the psychopharmacological agent clopenthixol and its two main metabolites.
Acta Pathol Microbiol Immunol Scand B. 1987 Dec;95(6):355-9. doi: 10.1111/j.1699-0463.1987.tb03138.x.
7
Synergy between a non-neuroleptic thioxanthene stereo-isomer and penicillin in vivo.
APMIS. 1988 Dec;96(12):1079-84. doi: 10.1111/j.1699-0463.1988.tb00984.x.
8
Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.噻吨类化合物对人源和鼠源细胞系多药耐药逆转作用的细胞及生化特性研究
Cancer Res. 1990 Mar 15;50(6):1748-56.
9
Chlorpromazine: a drug potentially useful for treating mycobacterial infections.氯丙嗪:一种可能对治疗分枝杆菌感染有用的药物。
Chemotherapy. 1992;38(6):410-9. doi: 10.1159/000239036.
10
Studies on antituberculotic action of some phenothiazine derivatives in vitro.某些吩噻嗪衍生物体外抗结核作用的研究。
Zentralbl Bakteriol Orig A. 1977 Dec;239(4):521-6.

引用本文的文献

1
Intramolecular Friedel-Crafts Reaction with Trifluoroacetic Acid: Synthesizing Some New Functionalized 9-Aryl/Alkyl Thioxanthenes.与三氟乙酸的分子内傅克反应:合成一些新型官能化9-芳基/烷基噻吨
ACS Omega. 2024 Mar 8;9(11):12596-12601. doi: 10.1021/acsomega.3c07150. eCollection 2024 Mar 19.
2
Consistency across multi-omics layers in a drug-perturbed gut microbial community.药物扰动肠道微生物群落中多组学层面的一致性。
Mol Syst Biol. 2023 Sep 12;19(9):e11525. doi: 10.15252/msb.202311525. Epub 2023 Jul 24.
3
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade.
用于结核病治疗的潜在重新利用药物候选物:十多年来已确定药物的进展与更新
ACS Omega. 2023 May 10;8(20):17362-17380. doi: 10.1021/acsomega.2c05511. eCollection 2023 May 23.
4
A Double-Edged Sword: Thioxanthenes Act on Both the Mind and the Microbiome.一把双刃剑:噻吨酮既作用于大脑也作用于微生物组。
Molecules. 2021 Dec 29;27(1):196. doi: 10.3390/molecules27010196.
5
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.多粘菌素B与美国食品药品监督管理局(FDA)批准的针对革兰氏阴性病原体多重耐药性的非抗生素吩噻嗪类药物联合使用。
Comput Struct Biotechnol J. 2020 Aug 21;18:2247-2258. doi: 10.1016/j.csbj.2020.08.008. eCollection 2020.
6
Psychotropics and the Microbiome: a Chamber of Secrets….精神药物与微生物组:一个秘密的房间……
Psychopharmacology (Berl). 2019 May;236(5):1411-1432. doi: 10.1007/s00213-019-5185-8. Epub 2019 Feb 26.
7
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.硫利达嗪:一种非抗生素药物,由于其多作用机制,与一线抗结核药物联合使用时,对任何形式的结核分枝杆菌抗生素耐药性均具有高效。
Antibiotics (Basel). 2017 Jan 14;6(1):3. doi: 10.3390/antibiotics6010003.
8
Mycobacterium tuberculosis induces an atypical cell death mode to escape from infected macrophages.结核分枝杆菌诱导一种非典型的细胞死亡模式以逃避被感染的巨噬细胞。
PLoS One. 2011 Mar 31;6(3):e18367. doi: 10.1371/journal.pone.0018367.
9
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.II型烟酰胺腺嘌呤二核苷酸(NADH):甲萘醌氧化还原酶抑制剂是一类抗结核药物。
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4548-53. doi: 10.1073/pnas.0500469102. Epub 2005 Mar 14.
10
Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.硫利达嗪的临床浓度可杀死细胞内耐多药结核分枝杆菌。
Antimicrob Agents Chemother. 2003 Mar;47(3):917-22. doi: 10.1128/AAC.47.3.917-922.2003.